These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1796533)

  • 21. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory peptic ulcers.
    Arakawa T; Kobayashi K; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern drugs used in the treatment of peptic ulcer].
    Ignat'ev MV
    Med Sestra; 1988 May; 47(5):41-6. PubMed ID: 3412153
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
    Hentschel E
    Wien Klin Wochenschr; 1994; 106(17):543-6. PubMed ID: 7975668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term therapy of peptic ulcer].
    Berndt H
    Z Arztl Fortbild (Jena); 1992 Mar; 86(6):287-90. PubMed ID: 1590008
    [No Abstract]   [Full Text] [Related]  

  • 30. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.
    Yeomans ND
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):447-55. PubMed ID: 21780891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
    Pohle T; Hilker E; Domschke W
    Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
    Einecke D
    MMW Fortschr Med; 2000 Jul; 142(26-27):50-1. PubMed ID: 10929487
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
    Boixeda de Miquel D
    Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.